Amarin (STU:EH3) Short Interest


STU:EH3 Amarin Corp PLC STU:EH3
54 GF Score
Price €13.90
GF Value €10.41
! 3 Warning Signs
View Full Analysis

What is Amarin Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:EH3 vs SCLX, MIRA, NSRX: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Amarin's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amarin Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amarin's Short Interest distribution charts can be found below:

* The bar in red indicates where Amarin's Short Interest falls into.


STU:EH3
54GF Score
Amarin Corp PLC STU:EH3
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Amarin (STU:EH3) Overvalued in 2026?

Based on GuruFocus' analysis, Amarin stock appears to be overvalued. The current stock price of €13.90 is trading 33.5% above its estimated GF Value™ of €10.41.

Key valuation signals for STU:EH3:

  • Short Interest:
  • GF Value™: €10.41 vs. price of €13.90 (33.5% above fair value)
  • GF Score™: 54/100 with 3 warning signs

No single metric tells the full story. See the STU:EH3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amarin Business Description

Other Exchanges AMRN:USAEH3:Germany
Address 36 Dame Street, 8th Floor, One Central Plaza, Dublin, IRL, D02 K7K5
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
54GF Score

Get the complete analysis for STU:EH3

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.90
Price
€10.41
GF Value